Publicacións nas que colabora con María Jesús Monte Río (27)

2020

  1. Role of genetic variations in the hepatic handling of drugs

    International Journal of Molecular Sciences, Vol. 21, Núm. 8

2019

  1. Epigenetic events involved in organic cation transporter 1-dependent impaired response of hepatocellular carcinoma to sorafenib

    British Journal of Pharmacology, Vol. 176, Núm. 6, pp. 787-800

2016

  1. Protective role of biliverdin against bile acid-induced oxidative stress in liver cells

    Free Radical Biology and Medicine, Vol. 97, pp. 466-477

2014

  1. The role of reduced intracellular concentrations of active drugs in the lack of response to anticancer chemotherapy

    Acta Pharmacologica Sinica, Vol. 35, Núm. 1, pp. 1-10

2013

  1. Genetic Variants Involved in Intracellular Mechanisms of Chemoresistance to Anticancer Drugs Due to Changes in the Effect on Their Molecular Targets

    eLS

2011

  1. A homozygous nonsense mutation (c.214C→A) in the biliverdin reductase alpha gene (BLVRA) results in accumulation of biliverdin during episodes of cholestasis

    Journal of Medical Genetics, Vol. 48, Núm. 4, pp. 219-225

2007

  1. Expression in Human Trophoblast and Choriocarcinoma Cell Lines, BeWo, Jeg-3 and JAr of Genes Involved in the Hepatobiliary-like Excretory Function of the Placenta

    Placenta, Vol. 28, Núm. 2-3, pp. 107-117

  2. Novel bile acid derivatives (BANBs) with cytostatic activity obtained by conjugation of their side chain with nitrogenated bases

    Biochemical Pharmacology, Vol. 73, Núm. 9, pp. 1394-1404

2006

  1. Effect of maternal cholestasis and treatment with ursodeoxycholic acid on the expression of genes involved in the secretion of biliary lipids by the neonatal rat liver

    Life Sciences, Vol. 79, Núm. 10, pp. 1014-1019

  2. Potential role of trans-inhibition of the bile salt export pump by progesterone metabolites in the etiopathogenesis of intrahepatic cholestasis of pregnancy

    Journal of Hepatology, Vol. 44, Núm. 6, pp. 1150-1157

2005

  1. Long-term effect of treating pregnant rats with ursodeoxycholic acid on the congenital impairment of bile secretion induced in the pups by maternal cholestasis

    Journal of Pharmacology and Experimental Therapeutics, Vol. 312, Núm. 2, pp. 751-758

2003

  1. Physiological characteristics of allo-cholic acid

    Journal of Lipid Research, Vol. 44, Núm. 1, pp. 84-92

2001

  1. Estudio preclínico del Bamet-U2, un nuevo citostático no nefrotóxico derivado del cisplatino

    Mapfre Medicina, Vol. 12, Núm. 1, pp. 33-38

  2. Predominance of human versus rat phenotype in the metabolic pathways for bile acid synthesis by hybrid WIF-B9 cells

    Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, Vol. 1534, Núm. 1, pp. 45-55

2000

  1. Comparison of the effects of bile acids on cell viability and DNA synthesis by rat hepatocytes in primary culture

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1500, Núm. 2, pp. 153-160

1999

  1. Cholephilic characteristics of a new cytostatic complex of cisplatin with glycocholate (Bamet-R2)

    Journal of Controlled Release, Vol. 57, Núm. 2, pp. 161-169

1998

  1. Beneficial effect of ursodeoxycholic acid on alterations induced by cholestasis of pregnancy in bile acid transport across the human placenta

    Journal of Hepatology, Vol. 28, Núm. 5, pp. 829-839

  2. DNA interaction and cytostatic activity of the new liver organotropic complex of cisplatin with glycocholic acid: Bamet-R2

    International Journal of Cancer, Vol. 78, Núm. 3, pp. 346-352

  3. In vitro test to determine the effect of cytostatic drugs on co-cultured rat hepatocytes and hepatoma cells

    International Journal of Experimental Pathology, Vol. 79, Núm. 2, pp. 109-115

1997

  1. Effect of maternal cholestasis on biliary lipid and bile acid secretion in the infant rat

    Hepatology, Vol. 26, Núm. 3, pp. 527-536